Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
-
Field
-
be confident engaging with young people. About the role - Grade H (15 month contract) We have an opportunity for a fifteen (15) month Research Fellow to support a small team conducting secondary data
-
only measure one point in space, but sensors mounted to unmanned aircraft are noisy and can only fly for a short time. We are addressing this challenge by building an autonomous, mobile gas flux tower
-
salary is normally in the range £36,130 to £45,413 with potential progression once in post to £48,149 Grade: 7 Full Time, Fixed Term contract up to August 2028 Closing date: 17th August 2025 Please note
-
Information - Personvernregler for databehandling Utløpsdato: ett år Navn: CookieInformationConsent Leverandør: www.jobbnorge.no Databehandlingsansvarlig: HAProxy software Formål: Kreves for at nettsiden skal
-
time starting salary is normally in the range £36,130 to £45,413 with potential progression once in post to £48,149 Grade: 7 Full Time, Fixed Term contract up to August 2028 Closing date: 25th August
-
for databehandling Utløpsdato: ett år Navn: CookieInformationConsent Leverandør: www.jobbnorge.no Databehandlingsansvarlig: HAProxy software Formål: Kreves for at nettsiden skal fungere riktig. Personvernregler
-
Information - Personvernregler for databehandling Utløpsdato: ett år Navn: CookieInformationConsent Leverandør: www.jobbnorge.no Databehandlingsansvarlig: HAProxy software Formål: Kreves for at nettsiden skal
-
attract, inspire, and develop outstanding people in medicine, sciences, and healthcare to become one of the world’s most distinguished academic health systems. In some way, great or small, every person
-
: .jobbnorge.no Databehandlingsansvarlig: HAProxy software Formål: Kreves for at nettsiden skal fungere riktig. Personvernregler for databehandling: HAProxy software - Personvernregler for databehandling Utløpsdato
-
, Preclinical Safety (PCS) is responsible for creating and executing development plans that support novel drug candidates from nonclinical testing through first-in-human, registration, and post-marketing phases